SITC Cancer Immunotherapy Guideline News

2026 ASCO Annual Meeting Scientific Highlights - June 2

posted 2 hours ago
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, June 2, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific ...
0 comments

2026 ASCO Annual Meeting Scientific Highlights - June 1

posted yesterday
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, June 1, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific ...
0 comments

2026 ASCO Annual Meeting Scientific Highlights - May 31

posted 2 days ago
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, May 31, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific ...
0 comments

Immune Monitor - May 2026

posted 2 days ago
A Message from the President The pace of discovery in cancer immunotherapy continues to accelerate, creating both extraordinary opportunity and an urgent need for collaboration. For more than 40 years, the Society ...
0 comments

2026 ASCO Annual Meeting Scientific Highlights - May 30

posted 3 days ago
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, May 30, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific ...
0 comments

2026 ASCO Annual Meeting Scientific Highlights - May 29

posted 4 days ago
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, May 29, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific ...
0 comments

SITC Signs onto ACS CAN Letter Urging Protection of the USPSTF

posted 6 days ago
The Society for Immunotherapy of Cancer (SITC) joined more than 60 cancer patient and provider organizations in signing onto a coalition letter led by the American Cancer Society Cancer Action Network (ACS CAN) directed ...
0 comments

NEW! The Role of Local Immunotherapy in the Treatment of Cancer

posted 7 days ago
Edited by Tanja D. de Gruijl, PhD and Howard Kaufman, MD, FACS While local immunotherapy has the potential to deliver high doses of immune potentiating agents with limited systemic toxicity, clinical development and ...
0 comments

SITC Signs onto OVAC Letter Supporting Timely Cancer Research Funding

posted 11 days ago
The Society for Immunotherapy of Cancer (SITC) joined more than 50 organizations through One Voice Against Cancer (OVAC) in signing a coalition letter to Congress raising concerns about delays and disruptions in federal cancer ...
0 comments

SITC 2026 Keynote and Registration Press Release

posted 13 days ago
SITC Announces Keynote Speakers Dr. Ton Schumacher and Dr. Catherine J. Wu at its 41 st Annual Meeting The largest cancer immunotherapy conference featuring the latest research in immuno-oncology MILWAUKEE, ...
0 comments

JITC Digest May 2026

posted 14 days ago
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks| JITC Meet-the-Editor Session at ASCO| Popular Articles Letter from the Editor Hello JITC Readers, This ...
0 comments

Immune Monitor - April 2026

posted 20 days ago
A Message from the President Staying current in immuno-oncology has never been more important—or more complex. With rapid advances across research, clinical practice, and regulation, access to timely, trusted education ...
0 comments

SITC Signs onto ASGCT Letter Supporting Cancer Research Funding

posted 22 days ago
As Congress begins deliberations on Fiscal Year 2027 (FY27) appropriations, continued investment in the National Institutes of Health (NIH) remains essential to sustaining progress in biomedical research and innovation. The ...
0 comments

2026 AACR Annual Meeting Scientific Highlights

posted 04-23-2026
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 AACR Annual Meeting, April 17–22, 2026. (Thanks to Jennifer Anderson, MD, PhD and Terri Holzen, PhD for compiling these ...
0 comments

JITC Digest April 2026

posted 04-15-2026
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks| JITC Meet-the-Editor Session at AAI| Popular Archive Articles Letter from the Editor Hello JITC Readers, ...
0 comments

Immune Monitor - March 2026

posted 03-27-2026
A Message from the President One of the most impactful ways the Forward Fund supports early-career investigators is through its fellowship program . These awards provide critical funding and mentorship to help launch ...
0 comments

SITC Publishes Renal Cell Carcinoma Clinical Practice Guideline version 3.0

posted 03-25-2026
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a guideline update, “Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal ...
0 comments

SITC Publishes Expert Insights on ICI-Related irAE Survivorship Care

posted 03-23-2026
The Society for Immunotherapy of Cancer is pleased to announce the publication of a new article, “ Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: Expert insights from SITC ...
0 comments

Oncology News Burst from the FDA: FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma

posted 03-23-2026
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists ...
0 comments

JITC Digest March 2026

posted 03-18-2026
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks|Special Series: SITC 40 th Anniversary| Popular Archive Articles Letter from the Editor Hello JITC Readers, ...
0 comments

Back to SITC Cancer Immunotherapy Guidelines